SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 232 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $10,182,000 | -21.4% | 2,189,700 | +28.9% | 1.48% | -15.5% |
Q3 2021 | $12,957,000 | +11.6% | 1,698,107 | +41.7% | 1.75% | +7.0% |
Q2 2021 | $11,608,000 | +31.8% | 1,197,976 | +12.5% | 1.64% | -4.5% |
Q1 2021 | $8,807,000 | +30.3% | 1,064,933 | +75.6% | 1.71% | +69.9% |
Q3 2020 | $6,760,000 | +1177.9% | 606,298 | +111.0% | 1.01% | +358.6% |
Q1 2020 | $529,000 | +475.0% | 287,386 | +957.4% | 0.22% | +746.2% |
Q4 2019 | $92,000 | – | 27,178 | -67.9% | 0.03% | – |
Q4 2018 | $0 | -100.0% | 84,536 | +388.6% | 0.00% | -100.0% |
Q2 2017 | $35,000 | -78.4% | 17,300 | -17.6% | 0.00% | -66.7% |
Q3 2016 | $162,000 | -88.6% | 20,986 | -91.7% | 0.01% | -91.9% |
Q2 2016 | $1,421,000 | -30.4% | 253,805 | -33.2% | 0.07% | -27.5% |
Q1 2016 | $2,043,000 | -21.8% | 379,800 | +26.6% | 0.10% | -29.2% |
Q4 2015 | $2,613,000 | +86.4% | 300,000 | +79.6% | 0.14% | +148.3% |
Q3 2015 | $1,402,000 | -22.0% | 167,064 | -24.8% | 0.06% | -49.6% |
Q4 2013 | $1,798,000 | – | 222,026 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 6,000,000 | $66,900,000 | 2.57% |
SABBY MANAGEMENT, LLC | 606,298 | $6,760,000 | 1.01% |
Virtus ETF Advisers LLC | 66,851 | $745,000 | 0.39% |
Newbridge Financial Services Group, Inc. | 26,900 | $300,000 | 0.30% |
Avidian Wealth Solutions, LLC | 330,000 | $3,680,000 | 0.28% |
Spectrum Wealth Advisory Group, LLC | 36,692 | $422,000 | 0.27% |
COWEN AND COMPANY, LLC | 129,200 | $1,441,000 | 0.24% |
Cormorant Asset Management, LP | 500,000 | $5,575,000 | 0.21% |
SYMMETRY PEAK MANAGEMENT LLC | 27,500 | $307,000 | 0.20% |
Aristides Capital LLC | 24,302 | $271,000 | 0.19% |